Institutional Clinical and Translational Science Award

联系PD/PI：FITZGERALD，GARRET A 整体 摘要/总结 转化医学和治疗研究所是CTSA的学术之家， 宾夕法尼亚州在过去的15年里，ITMAT的目标一直是而且仍然是： 增加有能力在有证据证明 细胞和模型系统中的概念，以及（ii）阐明人体生理学的机制， 疾病或药物的作用，通过强烈的表型在少数人。两 我们的CTSA的优先事项是促进转化治疗领域，并弥合 从儿科到成人，跨越了临床和转化科学的整个范围。这 本节介绍了这些优先事项如何影响CTSA中心的发展，并概述了 我们对未来融资期的计划。 项目摘要/摘要第136页 联系PD/PI：FITZGERALD，GARRET A 整体 叙事 转化医学和治疗研究所是CTSA的学术之家， 宾夕法尼亚州在过去十年中，ITMAT的具体目标一直是而且仍然是：㈠增加 能够在细胞概念验证之间进行研究的研究人员人数 和模型系统，以及（ii）阐明人类生理学、疾病或 药物作用通过在少数人中的强烈表型。

Contact PD/PI: FITZGERALD, GARRET A OVERALL ABSTRACT/SUMMARY The Institute for Translational Medicine and Therapeutics is the academic home for the CTSA in Penn. For the past decade and a half the objectives of ITMAT have been and remain (i) to increase the number of investigators capable of pursuing their research between proof of concept in cells and model systems and (ii) elucidation of the mechanisms of human physiology, disease or drug action through intense phenotyping in small numbers of people. The two priorities of our CTSA are to foster the field of translational therapeutics and to bridge the pediatric to adult divide across the entire spectrum of clinical and translational science. This section describes how these priorities have influenced the growth of this CTSA Hub and outlines our plans for the coming funding period. Project Summary/Abstract Page 136 Contact PD/PI: FITZGERALD, GARRET A OVERALL NARRATIVE The Institute for Translational Medicine and Therapeutics is the academic home for the CTSA in Penn. For the past decade the specific aims of ITMAT have been and remain (i) to increase the number of investigators capable of pursuing their research between proof of concept in cells and model systems and (ii) elucidation of the mechanisms of human physiology, disease or drug action through intense phenotyping in small numbers of people.